Works by Cook, Gordon


Results: 196
    1
    2

    Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim analysis of an open-label randomised controlled trial.

    Published in:
    2021
    By:
    • Jackson, Graham H.;
    • Pawlyn, Charlotte;
    • Cairns, David A.;
    • de Tute, Ruth M.;
    • Hockaday, Anna;
    • Collett, Corinne;
    • Jones, John R.;
    • Kishore, Bhuvan;
    • Garg, Mamta;
    • Williams, Cathy D.;
    • Karunanithi, Kamaraj;
    • Lindsay, Jindriska;
    • Rocci, Alberto;
    • Snowden, John A.;
    • Jenner, Matthew W.;
    • Cook, Gordon;
    • Russell, Nigel H.;
    • Drayson, Mark T.;
    • Gregory, Walter M.;
    • Kaiser, Martin F.
    Publication type:
    journal article
    3
    4
    5
    6
    7
    8
    9
    10

    Toftanes: The Paleoecology of a Faroese Landnám Farm.

    Published in:
    Human Ecology: An Interdisciplinary Journal, 2005, v. 33, n. 5, p. 685, doi. 10.1007/s10745-005-4744-2
    By:
    • Vickers, Kim;
    • Bending, Joanna;
    • Buckland, Paul C.;
    • Edwards, Kevin J.;
    • Hansen, Steffen Stummann;
    • Cook, Gordon
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17

    Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 2, p. 1, doi. 10.1038/s41408-021-00432-4
    By:
    • Terpos, Evangelos;
    • Mikhael, Joseph;
    • Hajek, Roman;
    • Chari, Ajai;
    • Zweegman, Sonja;
    • Lee, Hans C.;
    • Mateos, María-Victoria;
    • Larocca, Alessandra;
    • Ramasamy, Karthik;
    • Kaiser, Martin;
    • Cook, Gordon;
    • Weisel, Katja C.;
    • Costello, Caitlin L.;
    • Elliott, Jennifer;
    • Palumbo, Antonio;
    • Usmani, Saad Z.
    Publication type:
    Article
    18

    Daratumumab, lenalidomide, and dexamethasone in relapsed/refractory myeloma: a cytogenetic subgroup analysis of POLLUX.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 11, p. 1, doi. 10.1038/s41408-020-00375-2
    By:
    • Kaufman, Jonathan L.;
    • Dimopoulos, Meletios A.;
    • White, Darrell;
    • Benboubker, Lotfi;
    • Cook, Gordon;
    • Leiba, Merav;
    • Morton, James;
    • Joy Ho, P.;
    • Kim, Kihyun;
    • Takezako, Naoki;
    • Moreau, Philippe;
    • Sutherland, Heather J.;
    • Magen, Hila;
    • Iida, Shinsuke;
    • Kim, Jin Seok;
    • Miles Prince, H.;
    • Cochrane, Tara;
    • Oriol, Albert;
    • Bahlis, Nizar J.;
    • Chari, Ajai
    Publication type:
    Article
    19
    20
    21
    22
    23
    24

    Evidence for mummification in Bronze Age Britain.

    Published in:
    Antiquity, 2005, v. 79, n. 305, p. 529, doi. 10.1017/S0003598X00114486
    By:
    • Pearson, Mike Parker;
    • Chamberlain, Andrew;
    • Craig, Oliver;
    • Marshall, Peter;
    • Mulville, Jacqui;
    • Smith, Helen;
    • Chenery, Carolyn;
    • Collins, Matthew;
    • Cook, Gordon;
    • Craig, Geoffrey;
    • Evans, Jane;
    • Hiller, Jen;
    • Montgomery, Janet;
    • Schwenninger, Jean-Luc;
    • Taylor, Gillian;
    • Wess, Timothy
    Publication type:
    Article
    25

    How reliable are radiocarbon laboratories?

    Published in:
    Antiquity, 2003, v. 77, n. 295, p. 146, doi. 10.1017/S0003598X00061445
    By:
    • Boaretto, Elisabetta;
    • Bryant, Charlotte;
    • Carmi, Israel;
    • Cook, Gordon;
    • Gulliksen, Steinar;
    • Harkness, Doug;
    • Heinemeier, Jan;
    • McClure, John;
    • McGee, Edward;
    • Naysmith, Philip;
    • Possnert, Goran;
    • Scott, Marian;
    • van der Plicht, Hans;
    • van Strydonck, Mark
    Publication type:
    Article
    26
    27
    28
    29
    30

    Erratum to: Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma.

    Published in:
    Drugs, 2016, v. 76, n. 9, p. 989, doi. 10.1007/s40265-016-0590-3
    By:
    • Moreau, Philippe;
    • Donk, Niels;
    • Miguel, Jesus;
    • Lokhorst, Henk;
    • Nahi, Hareth;
    • Ben-Yehuda, Dina;
    • Cavo, Michele;
    • Cook, Gordon;
    • Delforge, Michel;
    • Einsele, Hermann;
    • Zweegman, Sonja;
    • Ludwig, Heinz;
    • Driessen, Christoph;
    • Palumbo, Antonio;
    • Facon, Thierry;
    • Plesner, Torben;
    • Dimopoulos, Meletios;
    • Sondergeld, Pia;
    • Sonneveld, Pieter;
    • Mateos, María-Victoria
    Publication type:
    Article
    31

    Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma.

    Published in:
    Drugs, 2016, v. 76, n. 8, p. 853, doi. 10.1007/s40265-016-0573-4
    By:
    • Moreau, Philippe;
    • Donk, Niels;
    • Miguel, Jesus;
    • Lokhorst, Henk;
    • Nahi, Hareth;
    • Ben-Yehuda, Dina;
    • Cavo, Michele;
    • Cook, Gordon;
    • Delforge, Michel;
    • Einsele, Hermann;
    • Zweegman, Sonja;
    • Ludwig, Heinz;
    • Driessen, Christoph;
    • Palumbo, Antonio;
    • Facon, Thierry;
    • Plesner, Torben;
    • Dimopoulos, Meletios;
    • Sondergeld, Pia;
    • Sonneveld, Pieter;
    • Mateos, María-Victoria
    Publication type:
    Article
    32

    Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma Patients.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 3, p. e171, doi. 10.1016/j.clml.2022.12.003
    By:
    • Thompson, Michael A.;
    • Boccadoro, Mario;
    • Leleu, Xavier;
    • Vela-Ojeda, Jorge;
    • Rhee, Frits van;
    • Weisel, Katja C.;
    • Rifkin, Robert M.;
    • Usmani, Saad Z.;
    • Hájek, Roman;
    • Cook, Gordon;
    • Abonour, Rafat;
    • Armour, Mira;
    • Morgan, Kathryn E.;
    • Yeh, Su-Peng;
    • Costello, Caitlin L.;
    • Berdeja, Jesus G.;
    • Davies, Faith E.;
    • Zonder, Jeffrey A.;
    • Lee, Hans C.;
    • Omel, Jim
    Publication type:
    Article
    33
    34
    35

    OAB-015: Minimal residual disease following autologous stem cell transplant for myeloma patients in the Myeloma XI trial: prognostic significance and the impact of lenalidomide maintenance and molecular risk.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S10, doi. 10.1016/S2152-2650(21)02089-9
    By:
    • De Tute, Ruth;
    • Pawlyn, Charlotte;
    • Cairns, David;
    • Davies, Faith;
    • Rawstron, Andy;
    • Jones, John;
    • Hockaday, Anna;
    • Menzies, Tom;
    • Henderson, Rowena;
    • Cook, Gordon;
    • Drayson, Mark;
    • Jenner, Matthew;
    • Kaiser, Martin;
    • Gregory, Walter;
    • Morgan, Gareth;
    • Jackson, Graham;
    • Owen, Roger
    Publication type:
    Article
    36

    OAB-013: Iberdomide (IBER) in combination with dexamethasone (DEX) and daratumumab (DARA), bortezomib (BORT), or carfilzomib (CFZ) in patients (pts) with relapsed/refractory multiple myeloma (RRMM).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S9, doi. 10.1016/S2152-2650(21)02087-5
    By:
    • Lonial, Sagar;
    • Richardson, Paul G.;
    • Popat, Rakesh;
    • Stadtmauer, Edward A.;
    • Larsen, Jeremy T.;
    • Oriol, A.;
    • Knop, Stefan;
    • Jagannath, Sundar;
    • Cook, Gordon;
    • Badros, Ashraf Z.;
    • Rodríguez-Otero, Paula;
    • Siegel, David S.;
    • Tuong Vi Nguyen;
    • Micco, Antonia Di;
    • Amin, Alpesh;
    • Min Chen;
    • Kueenburg, Elisabeth;
    • van de Donk, Niels W.C.J.
    Publication type:
    Article
    37

    OAB-012: Depth of response and MRD in newly diagnosed ultra high-risk myeloma and plasma cell leukemia treated with Dara-CVRd and V-MEL ASCT: results of the molecularly stratified UK OPTIMUM/MUKnine trial.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S8, doi. 10.1016/S2152-2650(21)02086-3
    By:
    • Kaiser, Martin;
    • Hall, Andrew;
    • Walker, Katrina;
    • Tute, Ruth De;
    • Roberts, Sadie;
    • Ingleson, Emma;
    • Bowles, Kristian;
    • Garg, Mamta;
    • Lokare, Anand;
    • Messiou, Christina;
    • Jackson, Graham;
    • Pratt, Guy;
    • Cook, Gordon;
    • Drayson, Mark;
    • Owen, Roger;
    • Brown, Sarah;
    • Jenner, Matthew
    Publication type:
    Article
    38
    39

    Outcomes of newly diagnosed multiple myeloma with deferred ASCT after achieving ≥VGPR following PAD induction in the Phase 2 PADIMAC study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e288, doi. 10.1016/j.clml.2019.09.475
    By:
    • Chan, Wei Yee;
    • Counsell, Nicholas;
    • Popat, Rakesh;
    • De Tute, Ruth;
    • De-silva, Dunnya;
    • Phillips, Elizabeth;
    • Cavenagh, Jamie;
    • Adedayo, Toyin;
    • Braganca, Nivette;
    • Roddie, Claire;
    • Streetly, Matthew;
    • Schey, Steve;
    • Koh, Mickey;
    • Crowe, Josephine;
    • Quinn, Michael;
    • Morris, Curly;
    • D'Sa, Shirley;
    • Virchis, Andres;
    • Cook, Gordon;
    • Crawley, Charles
    Publication type:
    Article
    40

    Sequential minimal residual disease (MRD) monitoring: Results from the UK Myeloma XI trial.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e45, doi. 10.1016/j.clml.2019.09.069
    By:
    • De Tute, Ruth;
    • Cairns, David;
    • Rawstron, Andrew;
    • Pawlyn, Charlotte;
    • Davies, Faith;
    • Jones, John;
    • Kaiser, Martin;
    • Hockaday, Anna;
    • Striha, Alina;
    • Cook, Gordon;
    • Russell, Nigel;
    • Drayson, Mark;
    • Jenner, Matthew;
    • Gregory, Walter;
    • Morgan, Gareth;
    • Jackson, Graham;
    • Owen, Roger
    Publication type:
    Article
    41

    A tale of two paradigms: fixed duration vs continuous therapy in routine clinical practice: An INSIGHT MM study analysis of duration of therapy.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e4, doi. 10.1016/j.clml.2019.09.006
    By:
    • Weisel, Katja;
    • Hungria, Vania;
    • Leleu, Xavier;
    • Lee, Hans;
    • Rifkin, Robert;
    • Costello, Caitlin;
    • Abonour, Rafat;
    • Chari, Ajai;
    • Puig, Noemi;
    • Berdeja, Jesus;
    • Cook, Gordon;
    • Thompson, Michael A.;
    • Boccadoro, Mario;
    • Terpos, Evangelos;
    • Zonder, Jeffrey A.;
    • Vela-Ojeda, Jorge;
    • Davies, Faith;
    • van Rhee, Frits;
    • Hajek, Roman;
    • Spencer, Andrew
    Publication type:
    Article
    42

    Quadruplet KCRD (Carfilzomib, Cyclophosphamide, Lenalidomide and Dexamethasone) Induction for Newly Diagnosed Myeloma Patients.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e2, doi. 10.1016/j.clml.2019.09.003
    By:
    • Pawlyn, Charlotte;
    • Davies, Faith;
    • Cairns, David;
    • Striha, Alina;
    • Hockaday, Anna;
    • Kishore, Bhuvan;
    • Garg, Mamta;
    • Williams, Cathy;
    • Karunanithi, Kamaraj;
    • Lindsay, Jindriska;
    • Jones, John;
    • Jenner, Matthew;
    • Russell, Nigel;
    • Cook, Gordon;
    • Kaiser, Martin;
    • Drayson, Mark;
    • Owen, Roger;
    • Gregory, Walter;
    • Morgan, Gareth;
    • Jackson, Graham
    Publication type:
    Article
    43
    44

    A Global Treatment Standard in Multiple Myeloma (MM) Remains Elusive Despite Advances in Care over 15 years: First Results from INSIGHT MM, the Largest Global Prospective, Observational MM Study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S247, doi. 10.1016/j.clml.2018.07.146
    By:
    • Costello, Caitlin;
    • Boccadoro, Mario;
    • Usmani, Saad Z.;
    • Chari, Ajai;
    • Rifkin, Robert M.;
    • Abonour, Rafat;
    • Berdeja, Jesus;
    • Cook, Gordon;
    • Goldschmidt, Hartmut;
    • Hajek, Roman;
    • Hungria, Vania;
    • Lee, Hans C.;
    • Leleu, Xavier;
    • Omel, Jim;
    • Spencer, Andrew;
    • Thompson, Michael A.;
    • Vela-Ojeda, Jorge;
    • Zonder, Jeffrey A.;
    • Puig, Noemi;
    • Aguarón, Alfonso
    Publication type:
    Article
    45
    46

    The Impact of Thalidomide, Zoledronate and High-dose Therapy with Autologous Stem Cell Support on Patient Reported Outcomes in Multiple Myeloma: Results of the Quality of Life Substudy of the MRC Myeloma IX Randomised Controlled Trial.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e121, doi. 10.1016/j.clml.2017.03.220
    By:
    • Cairns, David;
    • Royle, Kara-Louise;
    • Gregory, Walter;
    • Bell, Sue;
    • Cook, Gordon;
    • Owen, Roger;
    • Drayson, Mark;
    • Davies, Faith;
    • Morgan, Gareth;
    • Jackson, Graham;
    • Child, James
    Publication type:
    Article
    47

    Neutral Tumor Evolution in Myeloma is Associated With Poor Response to Therapy.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e10, doi. 10.1016/j.clml.2017.03.017
    By:
    • Johnson, David;
    • Lenive, Oleg;
    • Mitchell, Jonathan;
    • Ellis, Sidra;
    • Sherborne, Amy;
    • Shah, Vallari;
    • Jackson, Graham;
    • Owen, Roger;
    • Drayson, Mark;
    • Cook, Gordon;
    • Davies, Faith;
    • Pawlyn, Charlotte;
    • Jones, John;
    • Walker, Brian;
    • Wardell, Christopher;
    • Gregory, Walter;
    • Cairns, David;
    • Morgan, Gareth;
    • Houlston, Richard;
    • Kaiser, Martin
    Publication type:
    Article
    48

    Daratumumab, Lenalidomide and Dexamethasone (DRd) vs Lenalidomide and Dexamethasone (Rd) in RRMM Based on Prior Lines and Treatment Exposure: POLLUX.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e116, doi. 10.1016/j.clml.2017.03.211
    By:
    • Dimopoulos, Meletios;
    • Belch, Andrew R.;
    • White, Darrell J.;
    • Benboubker, Lofti;
    • Cook, Gordon;
    • Leiba, Merav;
    • Morton, James;
    • Ho, P. Joy;
    • Kim, Kihyun;
    • Takezako, Naoki;
    • San-Miguel, Jesus;
    • Moreau, Philippe;
    • Kaufman, Jonathan L.;
    • Sutherland, Heather;
    • Lalancette, Marc;
    • Magen, Hila;
    • Iida, Shinsuke;
    • Kim, Jin Seok;
    • Prince, H. Miles;
    • Cochrane, Tara
    Publication type:
    Article
    49

    The Impact of Maintenance Lenalidomide and Depth of Response on the Mutational Status of the Myeloma Clone from Presentation to Relapse.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e100, doi. 10.1016/j.clml.2017.03.181
    By:
    • Jones, John;
    • Weinhold, Niels;
    • Chavan, Shweta;
    • Pawlyn, Charlotte;
    • Melchor, Lorenzo;
    • Cairns, David;
    • Johnson, David;
    • Walker, Brian;
    • Wardell, Christopher;
    • Begum, Dil;
    • Ellis, Sidra;
    • Smith, Charlotte;
    • Sherborne, Amy;
    • Price, Amy;
    • Cook, Gordon;
    • Jenner, Matthew;
    • Russell, Nigel;
    • Drayson, Mark;
    • Owen, Roger;
    • Davies, Faith
    Publication type:
    Article
    50